A former Astrazeneca drugs manufacturing plant in Bristol has been bought by a Canadian property company for £18.5m.
The 100-acre Avlon site once produced statins and anti-psychotics but has now been bought by EDC from the administrator David Rubin & Partners.
EDC has brought in Maynards, an industrial auctions company, to manage the asset sales and demolition work before it redevelops the site as a warehousing and logistics park.
